Thalidomide inhibits the replication of human immunodeficiency virus type 1.
- 1 July 1993
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (13) , 5974-5978
- https://doi.org/10.1073/pnas.90.13.5974
Abstract
Thalidomide, a selective inhibitor of tumor necrosis factor alpha (TNF-alpha) synthesis, suppresses the activation of latent human immunodeficiency virus type 1 (HIV-1) in a monocytoid (U1) line. The inhibition is dose dependent and occurs after exposure of the cells to recombinant TNF-alpha, phorbol myristate acetate, lipopolysaccharide, and other cytokine combinations. Associated with HIV-1 inhibition is a reduction in agonist-induced TNF-alpha protein and mRNA production. Thalidomide inhibition of virus replication in the phorbol myristate acetate- and recombinant TNF-alpha-stimulated T-cell line ACH-2 is not observed. The presence of thalidomide also inhibits the activation of virus in the peripheral blood mononuclear cells of 16 out of 17 patients with advanced HIV-1 infection and AIDS. These results suggest the use of thalidomide in a clinical setting to inhibit both virus replication and the TNF-alpha-induced systemic toxicity of HIV-1 and opportunistic infections.Keywords
This publication has 18 references indexed in Scilit:
- Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha.1992
- The Effect of Cytokines and Pharmacologic Agents on Chronic HIV InfectionAIDS Research and Human Retroviruses, 1992
- Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.Proceedings of the National Academy of Sciences, 1989
- Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.Proceedings of the National Academy of Sciences, 1989
- Minireview: Induction of Expression of HIV in Latently or Chronically Infected CellsAIDS Research and Human Retroviruses, 1989
- Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.The Journal of Immunology, 1989
- Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.The Journal of Immunology, 1988
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.The Journal of Immunology, 1986
- Long-Term Cultures of HTLV-III—Infected T Cells: a Model of Cytopathology of T-Cell Depletion in AIDSScience, 1986